GlassScriptPhysician profile
Anthony Petrosini
NPI 1962481499
$2,638.18
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $55.55 · 2021: $59.88 · 2022: $141 · 2023: $145 · 2024: $1,841 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,348 · Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,348.00 |
| Food and Beverage | $781.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,758.92 | 2023-2025 | Comprehensive Shoulder System, Tricera Handpiece, Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $340.75 | 2019-2024 | Monovisc, Orthovisc |
| Bioventus LLC | $94.96 | 2019-2024 | Durolane |
| Stryker Corporation | $83.69 | 2024 | Inspace |
| Medshape, INC. | $81.58 | 2022 | |
| Ferring Pharmaceuticals INC. | $74.13 | 2019-2024 | Euflexxa |
| Treace Medical Concepts, INC. | $43.16 | 2023 | |
| Sanofi-Aventis U.S. LLC | $29.79 | 2019-2023 | |
| Biotronik Nro, INC. | $24.93 | 2023 | Biotronik |
| Djo, LLC | $18.24 | 2025 | Donjoy |
| Nevro Corp. | $17.97 | 2024 | Senza |
| Pacira Therapeutics, INC. | $15.43 | 2020 | |
| Orthogenrx INC. | $14.70 | 2020 | |
| Baxter Healthcare | $14.41 | 2019 | |
| Smith+Nephew, INC. | $13.42 | 2024 | Grafix Pl, Grafix, Stravix Pl |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. Dba Accelus | $12.10 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$500,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Petrosini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.